60 related articles for article (PubMed ID: 16487031)
1. Differential growth of IFN-beta-engineered tumor cells in nude and IFN receptor-null mice.
Zhang F; Lee J; Wang D; Dong Z
J Interferon Cytokine Res; 2006 Feb; 26(2):108-18. PubMed ID: 16487031
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
[TBL] [Abstract][Full Text] [Related]
3. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
[TBL] [Abstract][Full Text] [Related]
4. Active specific immunotherapy against occult brain metastasis.
Lu W; Su J; Kim LS; Bucana CD; Donawho C; He J; Fidler IJ; Dong Z
Cancer Res; 2003 Mar; 63(6):1345-50. PubMed ID: 12649197
[TBL] [Abstract][Full Text] [Related]
5. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.
Lu W; Fidler IJ; Dong Z
Cancer Res; 1999 Oct; 59(20):5202-8. PubMed ID: 10537298
[TBL] [Abstract][Full Text] [Related]
6. Metastatic behavior of an adriamycin-resistant murine tumor.
Giavazzi R; Miller L; Hart IR
Cancer Res; 1983 Nov; 43(11):5081-6. PubMed ID: 6616446
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
8. Therapy of human ovarian cancer by transfection with the murine interferon beta gene: role of macrophage-inducible nitric oxide synthase.
Xu L; Xie K; Fidler IJ
Hum Gene Ther; 1998 Dec; 9(18):2699-708. PubMed ID: 9874268
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.
Cao G; Su J; Lu W; Zhang F; Zhao G; Marteralli D; Dong Z
Cancer Gene Ther; 2001 Jul; 8(7):497-505. PubMed ID: 11498771
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Zhang F; Lu W; Dong Z
Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
[TBL] [Abstract][Full Text] [Related]
11. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
15. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
[TBL] [Abstract][Full Text] [Related]
16. Specific immunotherapy against occult cancer metastases.
Lu W; Dong Z; Donawho C; Fidler IJ
Int J Cancer; 2002 Aug; 100(4):480-5. PubMed ID: 12115534
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.
Olson MV; Lee J; Zhang F; Wang A; Dong Z
Cancer Gene Ther; 2006 Jul; 13(7):676-85. PubMed ID: 16470211
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.
Jablonska J; Leschner S; Westphal K; Lienenklaus S; Weiss S
J Clin Invest; 2010 Apr; 120(4):1151-64. PubMed ID: 20237412
[TBL] [Abstract][Full Text] [Related]
19. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Begovic M; Herberman R; Gorelik E
Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha beta reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase.
Jiang H; Rummage JA; Zhou A; Chen Z; Herriot MJ; Stewart CA; Kolosov M; Leu RW
J Immunol; 1996 Jul; 157(1):305-12. PubMed ID: 8683131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]